Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is plagued by a dismal 5-year survival rate, early onset of metastasis and limited efficacy of systemic therapies. This scenario highlights the need to fervently pursue novel therapeutic strategies to treat this disease. Recent research has uncovered complicat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Ware, Michael Brandon, El-Rayes, Bassel F, Lesinski, Gregory B
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449491/
https://ncbi.nlm.nih.gov/pubmed/32843336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001100
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars